Table 1.
Patient | Age | Gender | Duration of disease (years) | Duration of DBS (years) | Hoehn and Yahr | LED (mg) |
---|---|---|---|---|---|---|
PD1 | 51 | M | 11 | 2 | 2.5 | 400 |
PD2 | 64 | F | 16 | 1 | 2.5 | 1210 |
PD3 | 52 | M | 15 | 3 | 2 | 520 |
PD4 | 58 | M | 11 | 4 | 2 | 350 |
PD5 | 60 | M | 15 | 4 | 2 | 150 |
PD6 | 55 | M | 10 | 1 | 2 | 300 |
PD7 | 59 | M | 17 | 2 | 3 | 630 |
PD8 | 77 | M | 7 | 2 | 1.5 | 300 |
PD9 | 71 | F | 26 | 1 | 4 | 200 |
PD10 | 53 | M | 13 | 4 | 2 | 700 |
PD11 | 62 | F | 18 | 2 | 4 | 300 |
PD12 | 52 | M | 16 | 4 | 2 | 300 |
PD13 | 52 | M | 11 | 1 | 3 | 870 |
PD14 | 58 | M | 20 | 6 | 4 | 530 |
PD15 | 71 | F | 22 | 4 | 4 | 750 |
PD16 | 51 | M | 14 | 5 | 2 | 500 |
PD17 | 40 | M | 7 | 2 | 2 | 450 |
PD18 | 50 | F | 21 | 3 | 4 | 680 |
PD19 | 75 | F | 22 | 6 | 2 | 150 |
PD20 | 60 | M | 22 | 2 | 4 | 910 |
M = male; F = female; LED = l-DOPA equivalent dosage in mg.